Combination therapy for treating cancer
US10787440B2 · kind B2 · utility
8Cited by
12References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2019 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Apr 2, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.